Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy

Status:
Terminated

Trial end date:
2006-09-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the safety of TAK-128, once daily (QD), for treatment of diabetic peripheral neuropathy

Phase 2

Takeda